XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities:    
Net income (loss) $ 17,795 $ (22,152)
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:    
Depreciation and Amortization Expense 1,287 1,021
Deferred income taxes (976) (1,450)
Non-cash operating lease cost 1,719  
Stock-based compensation 26,288 68,280
Changes in operating assets and liabilities:    
Accounts receivable (5,927) 1,015
Due from related party 0 (501)
Inventory (82,020) (19,621)
Prepaid expenses and other current assets (6,470) (3,380)
Other assets (678) 91
Accounts payable 6,421 2,196
Accrued expenses 7,584 15,070
Deferred revenue 640 2,699
Accrued compensation and benefits (1,248) 1,902
Returns reserve 663 1,523
Sales tax payable (25) 2,359
Income tax payable (3,973) 2,961
Gift card liability 403 568
Deferred rent and lease incentive   (77)
Operating lease liabilities (1,336)  
Other non-current liabilities (28) 0
Net cash (used in) provided by operating activities (39,881) 52,504
Cash flows from investing activities:    
Purchases of property and equipment (4,256) (2,008)
Purchases of held-to-maturity securities (500) 0
Net cash used in investing activities (4,756) (2,008)
Cash flows from financing activities:    
Proceeds from issuance of Class A common stock in initial public offering, net of underwriting discounts 0 95,881
Payments of initial public offering issuance costs, net of reimbursements 0 (780)
Proceeds from stock option exercises and employee stock purchases 2,310 648
Tax payments related to net share settlements on restricted stock units 0 (21,556)
Payments of debt issuance costs 0 (169)
Capital contributions 479 1,301
Net cash provided by financing activities 2,789 75,325
Net (decrease) increase in cash, cash equivalents, and restricted cash (41,848) 125,821
Cash, cash equivalents, and restricted cash, beginning of period 197,430 58,133
Cash, cash equivalents, and restricted cash, end of period 155,582 183,954
Supplemental disclosures:    
Property and equipment included in accounts payable and accrued expenses 273 83
Deferred offering costs included in accounts payable and accrued expenses $ 0 $ 780